Our vision is to help increase cancer survival rate by 30% by 2030 and co-create the future of fighting cancer as well as other serious chronic diseases. We are cutting-edge Health Tech company specializing in connecting vast molecular biology with novel photonics technologies, chemistry & biomedical engineering to create solutions that can revolutionize healthcare worldwide, incl. first ever In Vivo Photonics Immunoassays platform technology inPROBE. We discover, develop and commercialize disruptive diagnostics and monitoring tools on a global scale and create lifesaving innovations which can help medical professionals in real-time diagnosis and monitoring as well as increase Patients’ well-being. We are a MedTech-Bio Powerhouse building strong and long-term R&D pipeline with Academia and early-stage startups to move Lifesaving Photonics Innovations from Science to the Market.